Menu Search
Equities

Braveheart Investment Group PLC

IQO:BER

Braveheart Investment Group PLC

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (EUR)0.0475
  • Today's Change-0.002 / -4.04%
  • Shares traded-1.00
  • 1 Year change-58.70%
  • Beta--
Data delayed at least 15 minutes, as of May 20 2024 07:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Braveheart Investment Group plc is a United Kingdom-based private equity and venture capital company. The Company divides its investments into two categories, namely strategic investments and portfolio investments. Its strategic investments include companies, including Paraytec Limited (Paraytec), Kirkstall Limited, Autins Group plc, Aukett Swanke Group plc and Image Scan Group plc. Paraytec develops specialist detectors for the analytical and life sciences instrumentation markets. Kirkstall Limited operates in the organ-on-a-chip market where it has developed Quasi Vivo, a system of chambers for cell and tissue culture in laboratories. Autins Group plc specializes in solving acoustic and thermal problems in the automotive industry and other specialist applications. Aukett Swanke Group plc provides architectural and interior design services in the primary international market sectors of offices, residential, education, industrial, hospitality and mixed use or hybrid developments.

  • Revenue in GBP (TTM)2.39m
  • Net income in GBP1.62m
  • Incorporated2003
  • Employees4.00
  • Location
    Braveheart Investment Group PLCCapitol Business Park, 1 Capitol CourtBARNSLEY S75 3TZUnited KingdomGBR
  • Phone+44 173 858 7555
  • Fax+44 173 858 7666
  • Websitehttps://braveheartgroup.co.uk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.